• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人角膜和巩膜对磺胺类碳酸酐酶抑制剂的通透性。

Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.

作者信息

Edelhauser H F, Maren T H

机构信息

Department of Physiology, Medical College of Wisconsin, Milwaukee 53226.

出版信息

Arch Ophthalmol. 1988 Aug;106(8):1110-5. doi: 10.1001/archopht.1988.01060140266039.

DOI:10.1001/archopht.1988.01060140266039
PMID:3401140
Abstract

Corneal penetration of sulfonamide carbonic anhydrase inhibitors for topical treatment of glaucoma has been tested in human eye bank and rabbit tissue. Paired corneas, with the epithelia intact or removed, and excised sclera were perfused in vitro. Corneal permeability (Kp) to methazolamide and ethoxzolamide was similar in both species, but for benzolamide and bromacetazolamide the Kp was greater in humans. Human corneas without epithelium had Kp the same as scleral Kp. Topical methazolamide (6 mmol/L) was studied in vivo in rabbits and in ten humans before cataract surgery. The mean (+/- SE) concentration in the rabbit aqueous was 3.2 +/- 1.4 mumol/L at eight minutes and 1.2 +/- 0.16 mumol/L at one hour. In humans, less than 0.2 mumol/L was detected at eight minutes; at one hour none was detected in three cases, and 0.4 +/- 0.08 mumol/L was detected in four cases. Lower permeability in humans than rabbits may result from a fourfold greater blinking rate, a twofold greater tear turnover, and a twofold lower corneal/conjunctival area.

摘要

用于青光眼局部治疗的磺胺类碳酸酐酶抑制剂的角膜穿透性已在人眼库组织和兔组织中进行了测试。将上皮完整或去除的配对角膜以及切除的巩膜进行体外灌注。两种物种中,角膜对甲唑酰胺和乙氧唑酰胺的渗透率(Kp)相似,但对于苯唑酰胺和溴醋唑酰胺,人的Kp更高。无上皮的人角膜的Kp与巩膜的Kp相同。在兔和十名白内障手术前的人中对局部用甲唑酰胺(6 mmol/L)进行了体内研究。兔房水中的平均(±SE)浓度在8分钟时为3.2±1.4 μmol/L,1小时时为1.2±0.16 μmol/L。在人中,8分钟时检测到的浓度低于0.2 μmol/L;1小时时,3例未检测到,4例检测到0.4±0.08 μmol/L。人比兔的渗透率低可能是由于眨眼频率高四倍、泪液更新率高两倍以及角膜/结膜面积低两倍所致。

相似文献

1
Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.人角膜和巩膜对磺胺类碳酸酐酶抑制剂的通透性。
Arch Ophthalmol. 1988 Aug;106(8):1110-5. doi: 10.1001/archopht.1988.01060140266039.
2
Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.6-羟基乙氧基-2-苯并噻唑磺酰胺的角膜和巩膜穿透性研究:一种局部碳酸酐酶抑制剂
J Ocul Pharmacol. 1990 Winter;6(4):313-20. doi: 10.1089/jop.1990.6.313.
3
The ocular distribution of methazolamide after corneal and scleral administration: the effect of ionization state.角膜和巩膜给药后甲唑酰胺的眼部分布:离子化状态的影响。
J Ocul Pharmacol Ther. 1998 Dec;14(6):565-73. doi: 10.1089/jop.1998.14.565.
4
Penetration into the anterior chamber via the conjunctival/scleral pathway.通过结膜/巩膜途径进入前房。
J Ocul Pharmacol Ther. 1997 Feb;13(1):41-59. doi: 10.1089/jop.1997.13.41.
5
Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor.pH对局部碳酸酐酶抑制剂眼部分布的影响。
Exp Eye Res. 1995 Aug;61(2):213-22. doi: 10.1016/s0014-4835(05)80041-7.
6
Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.
J Pharm Sci. 1985 May;74(5):525-9. doi: 10.1002/jps.2600740506.
7
Topical carbonic anhydrase inhibitors. III: Optimization model for corneal penetration of ethoxzolamide analogues.局部用碳酸酐酶抑制剂。III:乙氧唑胺类似物角膜渗透的优化模型。
J Pharm Sci. 1985 Feb;74(2):155-60. doi: 10.1002/jps.2600740210.
8
A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.局部和全身碳酸酐酶抑制剂对房水分泌影响的比较。
Exp Eye Res. 1993 Jul;57(1):67-78. doi: 10.1006/exer.1993.1100.
9
Ocular pharmacology of sulfonamides: the cornea as barrier and depot.磺胺类药物的眼药理学:角膜作为屏障和储存库。
Curr Eye Res. 1985 Apr;4(4):399-408. doi: 10.3109/02713688509025154.
10
Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.局部碳酸酐酶抑制剂L-643,799和L-650,719以及相关烷基前药的眼部分布研究。
J Ocul Pharmacol. 1988 Winter;4(4):279-90. doi: 10.1089/jop.1988.4.279.

引用本文的文献

1
Melanin-Binding-Based Discovery of Topically Instilled Carbonic Anhydrase Inhibitors for Targeted Delivery and Prolonged Action in the Eye.基于黑色素结合的局部滴注碳酸酐酶抑制剂的发现,用于眼部的靶向递送和长效作用。
Mol Pharm. 2025 Feb 3;22(2):721-732. doi: 10.1021/acs.molpharmaceut.4c00694. Epub 2025 Jan 9.
2
Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study.兔和猪角膜上皮转运蛋白表达:眼部药物转运研究模型评估。
Mol Pharm. 2024 Jul 1;21(7):3204-3217. doi: 10.1021/acs.molpharmaceut.3c01210. Epub 2024 May 29.
3
Bioequivalence Study Methods with Pharmacokinetic Endpoints for Topical Ophthalmic Corticosteroid Suspensions and Effects of Subject Demographics.
眼部皮质类固醇混悬剂的生物等效性研究方法及药代动力学终点与受试者特征的关系。
Pharm Res. 2018 Nov 15;36(1):13. doi: 10.1007/s11095-018-2537-8.
4
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.用于眼底药物输送、基因传递和成像的纳米医学。
Prog Retin Eye Res. 2013 Sep;36:172-98. doi: 10.1016/j.preteyeres.2013.04.001. Epub 2013 Apr 17.
5
Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.阳离子纳米结构杂脂基质用于甲唑胺眼部给药的设计。
Int J Nanomedicine. 2012;7:2483-96. doi: 10.2147/IJN.S28307. Epub 2012 May 17.
6
Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat.大鼠巩膜下生物可蚀性植入物中钠荧光素的清除。
Exp Eye Res. 2010 Apr;90(4):501-6. doi: 10.1016/j.exer.2010.01.001. Epub 2010 Jan 11.
7
Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.牛和猪的经巩膜溶质转运:亲脂性及脉络膜-布鲁赫膜的影响
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4513-22. doi: 10.1167/iovs.06-0404.
8
Periocular routes for retinal drug delivery.视网膜药物递送的眼周途径。
Expert Opin Drug Deliv. 2004 Nov;1(1):99-114. doi: 10.1517/17425247.1.1.99.
9
Enhancement of scleral macromolecular permeability with prostaglandins.前列腺素对巩膜大分子通透性的增强作用。
Trans Am Ophthalmol Soc. 2001;99:319-43.
10
Predicted permeability of the cornea to topical drugs.角膜对局部用药的预测通透性。
Pharm Res. 2001 Nov;18(11):1497-508. doi: 10.1023/a:1013061926851.